|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4439 | (2006.01) |
| A61P 35/00 | (2006.01) |
| (11) | Patento numeris | 3076969 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14812658.4 |
| Europos patento paraiškos padavimo data | 2014-12-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-10-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-09-01 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2014/066558 |
| Data | 2014-12-03 |
| (87) | Numeris | WO 2015/083101 |
| Data | 2015-06-11 |
| (30) | Numeris | Data | Šalis |
| 13306679 | 2013-12-06 | EP |
| (72) |
DI TOMASO, Emmanuelle , US
GERMA, Marie-Caroline , FR
MASSACESI, Cristian , FR
FRITSCH, Christine , CH
SCHNELL, Christian Rene , CH
TAVORATH, Ranjana , US
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | DOSAGE REGIMEN FOR AN ALPHA-ISOFORM SELECTIVE PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR |
| DOSAGE REGIMEN FOR AN ALPHA-ISOFORM SELECTIVE PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR |